Okupe Oluyemi's Form 4 filing
Hims & Hers Health, Inc. (HIMS) · filed Sep 17, 2025
- Accession no.
- 0001773751-25-000300
- Filed
- Sep 17, 2025
- Trade date
- Sep 15, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 5 derivative transactions. Open-market sales total $8.03M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Okupe OluyemiCIK 0001907056 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2025 | Class A Common Stock | MOption exerciseAcquired | +105,199 | –F1 | – | 222,005 | Direct | |
| Sep 15, 2025 | Class A Common Stock | FTax withholdingDisposed | −58,021 | $53.96 | −$3,130,813.16 | 163,984 | Direct | |
| Sep 15, 2025 | Class A Common Stock | MOption exerciseAcquired | +110,000 | $5.01 | +$551,100 | 273,984 | Direct | |
| Sep 15, 2025 | Class A Common Stock | SSaleDisposed | −117,792 | $55.25F4 | −$6,508,008 | 156,192 | Direct | |
| Sep 15, 2025 | Class A Common Stock | SSaleDisposed | −27,208 | $55.79F5 | −$1,517,934.32 | 128,984 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2025 | Class A Common Stock | MOption exerciseDisposed | −52,395 | $0.00 | $0 | 104,791 | Direct | |
| Sep 15, 2025 | Class A Common Stock | MOption exerciseDisposed | −18,334 | $0.00 | $0 | 110,007 | Direct | |
| Sep 15, 2025 | Class A Common Stock | MOption exerciseDisposed | −22,988 | $0.00 | $0 | 229,881 | Direct | |
| Sep 15, 2025 | Class A Common Stock | MOption exerciseDisposed | −11,482 | $0.00 | $0 | 160,755 | Direct | |
| Sep 15, 2025 | Class A Common Stock | MOption exerciseDisposed | −110,000 | $0.00 | $0 | 239,784 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
Referenced by the price of 1 transaction in Table I.
- F4
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $54.725 - $55.720. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.725 - $55.875. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.